logo

For the Inventor, By the Inventor

Ota, Japan

Kazuhiro Ohsuye

This inventor holds 15 USPTO granted patents, plus 2 CIPO patents. Top assignees: Suntory Limited, Asubio Pharma Co. Ltd., Other. Active years: 1993-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuhiro Ohsuye. Retrieved from https://idiyas.com/inventor/kazuhiro-ohsuye

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15

% Patents Active = 86.7


Average Co-Inventor Count = 3.3

ph-index = 6

Forward Citations = 210(Granted Patents)


Location History:

  • Osaka, JP (1993)
  • Ohra-gun, JP (1997 - 1998)
  • Ibaraki, JP (1998 - 2003)
  • Ohta, JP (1998 - 2008)
  • Gunma, JP (2009)
  • Ota, JP (2010)

Company Filing History:

goldMedal10 out of 439 
 
Suntory Limited
 patents
silverMedal3 out of 19 
 
Asubio Pharma Co. Ltd.
 patents
bronzeMedal3 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 1993-2010

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents
1. 7807421 - Process for production of biopterin compound (2010-10-05),
2. 7547529 - Methods for reducing the formation of by-products in the production of recombinant polypeptides (2009-06-16),
3. 7344856 - Method of controlling cleavage by OmpT protease (2008-03-18),
4. 6602681 - Enzymatic production of a C-terminal &agr;-amidated peptide or protein (2003-08-05),
5. 6262232 - Recombinant C-terminal &agr;-amidating enzyme (2001-07-17),
6. 6245887 - Recombinant C-terminal &agr;-amidating enzyme (2001-06-12),
7. 6037145 - Process for production of protein (2000-03-14),
8. 5976833 - Method for animal cell culture (1999-11-02),
9. 5955307 - Plasmid vector and use thereof for the production of interferon (1999-09-21),
10. 5834249 - Process for production of protein (1998-11-10),
11. 5821083 - Recombinant C-terminal .alpha.-amidating enzyme (1998-10-13),
12. 5747321 - Mutant Staphylococcus aureus V8 proteases (1998-05-05),
13. 5670340 - Process for producing peptides in E. coli (1997-09-23),
14. 5622840 - Method for controlling gene expression (1997-04-22),
15. 5252482 - Precursor of a C-terminal amidated calcitonin (1993-10-12),

Title: The Innovations of Kazuhiro Ohsuye

Introduction

Kazuhiro Ohsuye, a distinguished inventor based in Ota, Japan, holds an impressive portfolio of 15 patents. His work focuses on advancements in biochemistry and biotechnology, contributing significantly to the methodologies for producing various compounds and polypeptides.

Latest Patents

Among his latest patents is a revolutionary process for the production of biopterin compounds. This invention introduces a transformed cell capable of biosynthesizing tetrahydrobiopterin, offering an industrially advantageous method to produce biopterin compounds in large quantities using cost-effective materials. Another notable patent is for methods that reduce the formation of by-products in recombinant polypeptide production. This method involves enhancing the culture medium with histidine, methionine, or glycine to limit unwanted byproduct formation, optimizing the overall yield of desired polypeptides.

Career Highlights

Kazuhiro Ohsuye has made significant contributions while working for esteemed companies such as Suntory Limited and Asubio Pharma Co. Ltd. His expertise in the field of biochemistry and innovative approaches to bioproduction have positioned him as a leading figure in his industry.

Collaborations

Throughout his career, Ohsuye has collaborated with notable individuals in the field, including Masayuki Yabuta and Shoji Tanaka. These partnerships have facilitated valuable exchanges of ideas and research, further enhancing the impact of his inventions.

Conclusion

With a commitment to innovation and a solid foundation in biochemistry, Kazuhiro Ohsuye continues to push the boundaries of scientific research. His patents not only reflect his inventive spirit but also offer practical solutions to complex production challenges in biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…